Atlas Trials

Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer

Clinical trial NCT06893380 · RECRUITING

Trial details

NCT number
NCT06893380
Sponsor
CHA University
Status
RECRUITING
Study type
OBSERVATIONAL
Locally Advanced Biliary Tract CancersMetastatic Biliary Tract Cancers
Start date
2024-10-01
Primary completion
2026-05-08
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.